Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Incyte

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

There are some encouraging signs with other drugs however, including mid-stage clinical results with Incyte/Eli Lilly’s Olumiant (baricitinib), Johnson &Johnson’s IL-12/IL-23 inhibitor Stelara (ustekinumab)

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug

BMS buoyed by FDA approval of Celgene’s myelofibrosis drug Inrebic (fedratinib) is the second JAK inhibitor to be approved for myelofibrosis since Incyte’s Jakafi (ruxolitinib) was cleared by the FDA in 2011, and the first new treatment for the ... JAK1/2 inhibitor Jakafi is currently the only FDA-approved

J&J’s targeted bladder cancer treatment gets US approval

J&J’s targeted bladder cancer treatment gets US approval Despite the first-to-market personalised medicine claim for FGFR in bladder cancer, J&J could soon be joined by Incyte, which has its own oral FGFR inhibitor, Pemigatinib, in phase ... Incyte are also reviewing their candidate in advanced/metastatic or

Combined immunotherapies – potential and pitfalls

Combined immunotherapies – potential and pitfalls The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says.

CML-Life Patient Support Programme

Incyte listened to what we had to say, and developed something that we’ll actually use. ... CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics